Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Added value of chest computed tomography in suspected COVID-19: an analysis of 239 patients.
Korevaar DA, Kootte RS, Smits LP, van den Aardweg JG, Bonta PI, Schinkel J, Vigeveno RM, van den Berk IAH, Scheerder MJ, Lemkes BA, Goorhuis A, Beenen LFM, Annema JT; Amsterdam UMC location AMC COVID-19 group. Korevaar DA, et al. Eur Respir J. 2020 Aug 20;56(2):2001377. doi: 10.1183/13993003.01377-2020. Print 2020 Aug. Eur Respir J. 2020. PMID: 32675202 Free PMC article.
Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes.
Barry PJ, Mall MA, Álvarez A, Colombo C, de Winter-de Groot KM, Fajac I, McBennett KA, McKone EF, Ramsey BW, Sutharsan S, Taylor-Cousar JL, Tullis E, Ahluwalia N, Jun LS, Moskowitz SM, Prieto-Centurion V, Tian S, Waltz D, Xuan F, Zhang Y, Rowe SM, Polineni D; VX18-445-104 Study Group. Barry PJ, et al. N Engl J Med. 2021 Aug 26;385(9):815-825. doi: 10.1056/NEJMoa2100665. N Engl J Med. 2021. PMID: 34437784 Free PMC article. Clinical Trial.
Comparison of microbial composition of cough swabs and sputum for pathogen detection in patients with cystic fibrosis.
Fenn D, Abdel-Aziz MI, Brinkman P, Kos R, Neerincx AH, Altenburg J, Weersink E, Haarman EG, Terheggen-Lagro SWJ, Maitland-van der Zee AH, Bos LDJ; Amsterdam mucociliary clearance disease research group. Fenn D, et al. Among authors: altenburg j. J Cyst Fibros. 2022 Jan;21(1):52-60. doi: 10.1016/j.jcf.2021.08.031. Epub 2021 Sep 20. J Cyst Fibros. 2022. PMID: 34548223 Free article.
Primary ciliary dyskinesia in Volendam: Diagnostic and phenotypic features in patients with a CCDC114 mutation.
Kos R, Israëls J, van Gogh CDL, Altenburg J, Diepenhorst S, Paff T, Boon EMJ, Micha D, Pals G, Neerincx AH, Maitland-van der Zee AH, Haarman EG; Amsterdam Mucociliary Clearance Disease (AMCD) Research Group. Kos R, et al. Among authors: altenburg j. Am J Med Genet C Semin Med Genet. 2022 Mar;190(1):89-101. doi: 10.1002/ajmg.c.31968. Epub 2022 Mar 27. Am J Med Genet C Semin Med Genet. 2022. PMID: 35343062 Free PMC article.
The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN.
Raidt J, Maitre B, Pennekamp P, Altenburg J, Anagnostopoulou P, Armengot M, Bloemsma LD, Boon M, Borrelli M, Brinkmann F, Carr SB, Carroll MP, Castillo-Corullón S, Coste A, Cutrera R, Dehlink E, Destouches DMS, Di Cicco ME, Dixon L, Emiralioglu N, Erdem Eralp E, Haarman EG, Hogg C, Karadag B, Kobbernagel HE, Lorent N, Mall MA, Marthin JK, Martinu V, Narayanan M, Ozcelik U, Peckham D, Pifferi M, Pohunek P, Polverino E, Range S, Ringshausen FC, Robson E, Roehmel J, Rovira-Amigo S, Santamaria F, Schlegtendal A, Szépfalusi Z, Tempels P, Thouvenin G, Ullmann N, Walker WT, Wetzke M, Yiallouros P, Omran H, Nielsen KG. Raidt J, et al. Among authors: altenburg j. ERJ Open Res. 2022 Aug 15;8(3):00139-2022. doi: 10.1183/23120541.00139-2022. eCollection 2022 Jul. ERJ Open Res. 2022. PMID: 35983540 Free PMC article.
Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients.
Kos R, Neerincx AH, Fenn DW, Brinkman P, Lub R, Vonk SEM, Roukema J, Reijers MH, Terheggen-Lagro SWJ, Altenburg J, Majoor CJ, Bos LD, Haarman EG, Maitland-van der Zee AH; Amsterdam Mucociliary Clearance Disease (AMCD) Research Group. Kos R, et al. Among authors: altenburg j. Pharmacol Res Perspect. 2022 Dec;10(6):e01015. doi: 10.1002/prp2.1015. Pharmacol Res Perspect. 2022. PMID: 36440690 Free PMC article.
A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia.
Kos R, Goutaki M, Kobbernagel HE, Rubbo B, Shoemark A, Aliberti S, Altenburg J, Anagnostopoulou P, Athanazio RA, Beydon N, Dell SD, Emiralioglu N, Ferkol TW, Loebinger MR, Lorent N, Maître B, Marthin J, Morgan LC, Nielsen KG, Ringshausen FC, Shteinberg M, Tiddens HAWM, Maitland-Van der Zee AH, Chalmers JD, Lucas JSA, Haarman EG. Kos R, et al. Among authors: altenburg j. ERJ Open Res. 2024 Jan 8;10(1):00115-2023. doi: 10.1183/23120541.00115-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38196895 Free PMC article.
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey.
Shteinberg M, Boyd J, Aliberti S, Polverino E, Harris B, Berg T, Posthumus A, Ruddy T, Goeminne P, Lloyd E, Alan T, Altenburg J, Crossley B, Blasi F, Chalmers J. Shteinberg M, et al. Among authors: altenburg j. ERJ Open Res. 2021 Feb 15;7(1):00807-2020. doi: 10.1183/23120541.00807-2020. eCollection 2021 Jan. ERJ Open Res. 2021. PMID: 33614773 Free PMC article.
Bronchiectasis in Severe Asthma: Does It Make a Difference?
Bendien SA, van Loon-Kooij S, Kramer G, Huijgen W, Altenburg J, Ten Brinke A, Maitland-van der Zee AH. Bendien SA, et al. Among authors: altenburg j. Respiration. 2020 Dec 15:1-9. doi: 10.1159/000511459. Online ahead of print. Respiration. 2020. PMID: 33321494
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial.
van den Berk IAH, Kanglie MMNP, van Engelen TSR, Altenburg J, Annema JT, Beenen LFM, Boerrigter B, Bomers MK, Bresser P, Eryigit E, Groenink M, Hochheimer SMR, Holleman F, Kooter JAJ, van Loon RB, Keijzers M, van der Lee I, Luijendijk P, Meijboom LJ, Middeldorp S, Schijf LJ, Soetekouw R, Sprengers RW, Montauban van Swijndregt AD, de Monyé W, Ridderikhof ML, Winter MM, Bipat S, Dijkgraaf MGW, Bossuyt PMM, Prins JM, Stoker J; OPTIMACT study group. van den Berk IAH, et al. Among authors: altenburg j. Thorax. 2023 May;78(5):515-522. doi: 10.1136/thoraxjnl-2021-218337. Epub 2022 Jun 10. Thorax. 2023. PMID: 35688623 Free PMC article. Clinical Trial.
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration.
Aliberti S, Polverino E, Chalmers JD, Altenburg J, Shteinberg M, Goeminne PC, Welte T, Shoemark A, Almagro M, Blasi F; EMBARC Clinical Research Collaboration. Aliberti S, et al. Among authors: altenburg j. Eur Respir J. 2018 Nov 29;52(5):1802074. doi: 10.1183/13993003.02074-2018. Print 2018 Nov. Eur Respir J. 2018. PMID: 30498055 Free article. No abstract available.
Predicting factors for chronic colonization of Pseudomonas aeruginosa in bronchiectasis.
Pieters A, Bakker M, Hoek RAS, Altenburg J, van Westreenen M, Aerts JGJV, van der Eerden MM. Pieters A, et al. Among authors: altenburg j. Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2299-2304. doi: 10.1007/s10096-019-03675-z. Epub 2019 Aug 31. Eur J Clin Microbiol Infect Dis. 2019. PMID: 31471703 Free PMC article.
The effect of maintenance azithromycin on radiological features in patients with bronchiectasis - Analysis from the BAT randomized controlled trial.
Terpstra LC, Altenburg J, Mohamed Hoesein FA, Bronsveld I, Go S, van Rijn PAC, De Jong PA, Heijerman HGM, Boersma WG. Terpstra LC, et al. Among authors: altenburg j. Respir Med. 2022 Feb;192:106718. doi: 10.1016/j.rmed.2021.106718. Epub 2021 Dec 28. Respir Med. 2022. PMID: 34974413 Free article. Clinical Trial.
Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study.
Shoemark A, Shteinberg M, De Soyza A, Haworth CS, Richardson H, Gao Y, Perea L, Dicker AJ, Goeminne PC, Cant E, Polverino E, Altenburg J, Keir HR, Loebinger MR, Blasi F, Welte T, Sibila O, Aliberti S, Chalmers JD. Shoemark A, et al. Among authors: altenburg j. Am J Respir Crit Care Med. 2022 Apr 15;205(8):894-902. doi: 10.1164/rccm.202108-1889OC. Am J Respir Crit Care Med. 2022. PMID: 35050830
Heterogeneity of treatment response in bronchiectasis clinical trials.
Sibila O, Laserna E, Shoemark A, Perea L, Bilton D, Crichton ML, De Soyza A, Boersma WG, Altenburg J, Chalmers JD. Sibila O, et al. Among authors: altenburg j. Eur Respir J. 2022 May 5;59(5):2100777. doi: 10.1183/13993003.00777-2021. Print 2022 May. Eur Respir J. 2022. PMID: 34675045 Free article. Clinical Trial.
Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study.
Henriette Zweijpfenning SM, Chiron R, Essink S, Schildkraut J, Akkerman OW, Aliberti S, Altenburg J, Arets B, van Braeckel E, Delaere B, Gohy S, Haarman E, Lorent N, McKew G, Morgan L, Wagner D, van Ingen J, Hoefsloot W. Henriette Zweijpfenning SM, et al. Among authors: altenburg j. Chest. 2022 Jul;162(1):76-81. doi: 10.1016/j.chest.2022.01.015. Epub 2022 Jan 19. Chest. 2022. PMID: 35063454 Free PMC article. No abstract available.
The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol.
Terpstra LC, Altenburg J, Bronsveld I, Doodeman HJ, Rozemeijer W, Heijerman HGM, Boersma WG. Terpstra LC, et al. Among authors: altenburg j. Contemp Clin Trials Commun. 2022 Dec 6;30:101045. doi: 10.1016/j.conctc.2022.101045. eCollection 2022 Dec. Contemp Clin Trials Commun. 2022. PMID: 36531900 Free PMC article.
Rituximab in life threatening antisynthetase syndrome.
Vandenbroucke E, Grutters JC, Altenburg J, Boersma WG, ter Borg EJ, van den Bosch JM. Vandenbroucke E, et al. Among authors: altenburg j. Rheumatol Int. 2009 Oct;29(12):1499-502. doi: 10.1007/s00296-009-0859-x. Epub 2009 Feb 1. Rheumatol Int. 2009. PMID: 19184665
Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis1.
Janssen NAF, Nyga R, Vanderbeke L, Jacobs C, Ergün M, Buil JB, van Dijk K, Altenburg J, Bouman CSC, van der Spoel HI, Rijnders BJA, Dunbar A, Schouten JA, Lagrou K, Bourgeois M, Reynders M, van Regenmortel N, Rutsaert L, Lormans P, Feys S, Debavaye Y, Tamion F, Costa D, Maizel J, Dupont H, Chouaki T, Nseir S, Sendid B, Brüggemann RJM, van de Veerdonk FL, Wauters J, Verweij PE. Janssen NAF, et al. Among authors: altenburg j. Emerg Infect Dis. 2021 Nov;27(11):2892-2898. doi: 10.3201/eid2711.211174. Epub 2021 Sep 14. Emerg Infect Dis. 2021. PMID: 34519638 Free PMC article.
Coccidioidomycosis presenting years after returning from travel.
Korsten K, Altenburg J, Gittelbauer M, van Hengel P, Jansen R, van Dijk K. Korsten K, et al. Among authors: altenburg j. Med Mycol Case Rep. 2023 Dec 30;43:100623. doi: 10.1016/j.mmcr.2023.100623. eCollection 2024 Mar. Med Mycol Case Rep. 2023. PMID: 38283388 Free PMC article.
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC).
Chalmers JD, Polverino E, Crichton ML, Ringshausen FC, De Soyza A, Vendrell M, Burgel PR, Haworth CS, Loebinger MR, Dimakou K, Murris M, Wilson R, Hill AT, Menendez R, Torres A, Welte T, Blasi F, Altenburg J, Shteinberg M, Boersma W, Elborn JS, Goeminne PC, Aliberti S; EMBARC Registry Investigators. Chalmers JD, et al. Among authors: altenburg j. Lancet Respir Med. 2023 Jul;11(7):637-649. doi: 10.1016/S2213-2600(23)00093-0. Epub 2023 Apr 24. Lancet Respir Med. 2023. PMID: 37105206 Free article.
Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society Clinical Research Collaboration.
Chalmers JD, Aliberti S, Altenburg J, Blasi F, Clarke C, Chotirmall SH, Crichton ML, Dhar R, Goeminne P, Haworth C, Loebinger MR, Lorent N, Polverino E, Ringshausen FC, Shoemark A, Shteinberg M, Sibila O, Spinou A, Welte T. Chalmers JD, et al. Among authors: altenburg j. Eur Respir J. 2023 Jun 29;61(6):2300769. doi: 10.1183/13993003.00769-2023. Print 2023 Jun. Eur Respir J. 2023. PMID: 37385653 No abstract available.
The Association Between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC).
Polverino E, De Soyza A, Dimakou K, Traversi L, Bossios A, Crichton ML, Ringshausen FC, Vendrell M, Burgel PR, Haworth CS, Loebinger MR, Lorent N, Pink I, McDonnell M, Skrgat S, Maiz Carro L, Sibila O, Vd Eerden MM, Kauppi P, Shoemark A, Amorim A, Brown JS, Hurst JR, Miravitlles M, Menendez R, Torres A, Welte T, Blasi F, Altenburg J, Shteinberg M, Boersma W, Elborn SJ, Goeminne PC, Aliberti S, Chalmers JD. Polverino E, et al. Among authors: altenburg j. Am J Respir Crit Care Med. 2024 Jan 25. doi: 10.1164/rccm.202309-1614OC. Online ahead of print. Am J Respir Crit Care Med. 2024. PMID: 38271696
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Aliberti S, Ringshausen FC, Dhar R, Haworth CS, Loebinger MR, Dimakou K, Crichton ML, De Soyza A, Vendrell M, Burgel PR, McDonnell M, Skrgat S, Maiz Carro L, de Roux A, Sibila O, Bossios A, van der Eerden M, Kauppi P, Wilson R, Milenkovic B, Menendez R, Murris M, Borekci S, Munteanu O, Obradovic D, Nowinski A, Amorim A, Torres A, Lorent N, Van Braeckel E, Altenburg J, Shoemark A, Shteinberg M, Boersma W, Goeminne PC, Elborn JS, Hill AT, Welte T, Blasi F, Polverino E, Chalmers JD; EMBARC Registry Investigators. Aliberti S, et al. Among authors: altenburg j. Eur Respir J. 2024 Apr 18;63(4):2301554. doi: 10.1183/13993003.01554-2023. Print 2024 Apr. Eur Respir J. 2024. PMID: 38609095 Free PMC article.
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC).
Polverino E, Dimakou K, Traversi L, Bossios A, Haworth CS, Loebinger MR, De Soyza A, Vendrell M, Burgel PR, Mertsch P, McDonnell M, Škrgat S, Maiz Carro L, Sibila O, van der Eerden M, Kauppi P, Hill AT, Wilson R, Milenkovic B, Menendez R, Murris M, Digalaki T, Crichton ML, Borecki S, Obradovic D, Nowinski A, Amorim A, Torres A, Lorent N, Welte T, Blasi F, Van Braeckel E, Altenburg J, Shoemark A, Shteinberg M, Boersma W, Elborn JS, Aliberti S, Ringshausen FC, Chalmers JD, Goeminne PC; EMBARC registry investigators. Polverino E, et al. Among authors: altenburg j. J Allergy Clin Immunol. 2024 Feb 23:S0091-6749(24)00189-1. doi: 10.1016/j.jaci.2024.01.027. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 38401857 Free article.
Stepwise Introduction of Elexacaftor-Tezacaftor-Ivacaftor in Patients With Cystic Fibrosis and Liver Cirrhosis Child-Pugh A or B Using Clinical and Therapeutic Drug Monitoring: A Case Series.
Vonk SEM, Lub R, Weersink EJM, Beuers U, Mathôt RAA, Kemper EM, Altenburg J; Amsterdam Mucociliary Clearance Disease Research Group. Vonk SEM, et al. Among authors: altenburg j. Clin Ther. 2024 Feb;46(2):154-158. doi: 10.1016/j.clinthera.2023.11.003. Epub 2023 Dec 1. Clin Ther. 2024. PMID: 38042631 Free article.
Real-time online monitoring of insect cell proliferation and baculovirus infection using digital differential holographic microscopy and machine learning.
Altenburg JJ, Klaverdijk M, Cabosart D, Desmecht L, Brunekreeft-Terlouw SS, Both J, Tegelbeckers VIP, Willekens MLPM, van Oosten L, Hick TAH, van der Aalst TMH, Pijlman GP, van Oers MM, Wijffels RH, Martens DE. Altenburg JJ, et al. Biotechnol Prog. 2023 Mar;39(2):e3318. doi: 10.1002/btpr.3318. Epub 2022 Dec 23. Biotechnol Prog. 2023. PMID: 36512364
An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
van Oosten L, Yan K, Rawle DJ, Le TT, Altenburg JJ, Fougeroux C, Goksøyr L, Adriaan de Jongh W, Nielsen MA, Sander AF, Pijlman GP, Suhrbier A. van Oosten L, et al. Among authors: altenburg jj. J Virol. 2022 Jul 27;96(14):e0084422. doi: 10.1128/jvi.00844-22. Epub 2022 Jun 29. J Virol. 2022. PMID: 35766489 Free PMC article. No abstract available.
Implementation of Early Next-Generation Sequencing for Inborn Errors of Immunity: A Prospective Observational Cohort Study of Diagnostic Yield and Clinical Implications in Dutch Genome Diagnostic Centers.
Elsink K, Huibers MMH, Hollink IHIM, Simons A, Zonneveld-Huijssoon E, van der Veken LT, Leavis HL, Henriet SSV, van Deuren M, van de Veerdonk FL, Potjewijd J, Berghuis D, Dalm VASH, Vermont CL, van de Ven AAJM, Lambeck AJA, Abbott KM, van Hagen PM, de Bree GJ, Kuijpers TW, Frederix GWJ, van Gijn ME, van Montfrans JM; Genetics First for Primary Immunodeficiency Disorders Consortium. Elsink K, et al. Front Immunol. 2021 Dec 21;12:780134. doi: 10.3389/fimmu.2021.780134. eCollection 2021. Front Immunol. 2021. PMID: 34992599 Free PMC article.
Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants.
van Oosten L, Altenburg JJ, Fougeroux C, Geertsema C, van den End F, Evers WAC, Westphal AH, Lindhoud S, van den Berg W, Swarts DC, Deurhof L, Suhrbier A, Le TT, Torres Morales S, Myeni SK, Kikkert M, Sander AF, de Jongh WA, Dagil R, Nielsen MA, Salanti A, Søgaard M, Keijzer TMP, Weijers D, Eppink MHM, Wijffels RH, van Oers MM, Martens DE, Pijlman GP. van Oosten L, et al. Among authors: altenburg jj. mBio. 2021 Oct 26;12(5):e0181321. doi: 10.1128/mBio.01813-21. Epub 2021 Oct 12. mBio. 2021. PMID: 34634927 Free PMC article.